Detalhe da pesquisa
1.
A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial).
J Neurol Neurosurg Psychiatry
; 89(4): 330-338, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29248894